USP5影响非小细胞肺癌的免疫透和预后

Yonghong Xu1, Yifei Xie2, Jian Zhao2

  • 1Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou 215006, PR China; Department of Respiratory and Critical Care Medicine, The second Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, PR China; Suzhou Key Laboratory for Respiratory Diseases, Suzhou, Jiangsu 215006, PR China; Institute of Respiratory Diseases, Soochow University, Suzhou, Jiangsu 215006, PR China.

PubMed
概括

USP5在非小细胞肺癌 (NSCLC) 中升高,与免疫细胞减少相关. 这种deubiquitinating酶显示出作为NSCLC的诊断和预后标记物的潜力.